EVO

#2393
Evotec SE American Depositary Shares
3.1200 USD
+12.23%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
3.1200
3.1200
Годовой диапазон
2.3080
4.2700
Дневное изменение
+12.23%
Месячное изменение
+33.33%
6-месячное изменение
-26.93%
Годовое изменение
-26.93%
Предыдущее закрытие
2.7800
Открыть
3.1200
Bid
Ask
Минимум
3.1200
High
3.1200
Объем
3
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
Отчет о доходах Баланс Денежный поток
Значение 20212022202320242025 TTM

Evotec SE - American Depositary Shares each representing 1/2 of

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development. The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more. On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology.

Новости